Providers can sign up for early access here: To view or add a comment, sign in More Relevant Posts PCAC Meeting Day 1 Results: BPC-157: YES KPV: YES TB-500: YES MOTS-c: YES Today the FDA's Pharmacy Compounding Advisory Committee voted to recommend all four peptides reviewed today for inclusion on the 503A Bulks List
Baatenburg de long R, Bekhof J, Roorda R, Zwart P
He does point out that finding a physician who is familiar with and prescribes BPC-157 is pretty easy to do if you live someplace like Phoenix or New York or San Francisco, and pretty hard if you live in Iowa. As Timmermans and other experts note, its not hard to go online or on social and find pretty consistent advice on dosages and protocols
Food and Drug Administration for human or animal diagnosis, treatment, cure, mitigation, prevention, administration, or consumption
There's a sprawling sea of conflicting information out there, much of it anecdotal and lacking scientific rigor
As a physician, my view is through the lens of the patient in front of me. On Thursday, the panel voted 8-6 to add BPC-157 to the list for treating ulcerative colitis, to add KPV for wound healing and inflammatory conditions, and to add TB-500 for wound healing